[Sponsored] In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation. The post The Power of One: Redefining Healthcare with an AI-Driven Unified Platform appeared first on MedCity News.
KFF’s Tracking Poll on Health Information and Trust finds that just over half of adults use social media for health information and advice at least occasionally but fewer than half say they find “most” or “some” of the information they see on each platform trustworthy.
When you think about the opioid crisis, the image of adults in their 20s, 30s, even sometimes those who are middle-aged, may come to mind. Rightly so, since most overdose deaths occur in people between ages 25 and 64. But did you know older adults are increasingly at risk of overdosing from opioids, too? In fact, from 2021…
When workers feel stuck in place, with limited opportunities to advance or deepen their skills, disengagement tends to follow. In allied health roles, where burnout is already high and many touch the patient experience, it is a risk healthcare employers cannot afford to ignore. The post Healthcare Retention Depends On Better Pathways, Not Just Better…
Funding aims to expand virtual and in-home care, enhance clinical innovation, and support vulnerable pediatric populations nationwide
GLP-1s have proven to be highly effective for weight loss but pose significant cost challenges for employers, according to a recent panel of experts at MedCity INVEST. The post Are GLP-1s Worth the Hype? appeared first on MedCity News.
This policy brief highlights areas in which HHS, FDA, and CDC have authority to shape U.S. vaccine policy with a specific focus on vaccine approvals and recommendations for the public. Ultimately, while there are limits, federal officials have significant authority to influence and alter vaccine policy, which could affect vaccine availability, views about vaccines, and…
The assumption is intuitive and well-intentioned: if patients simply understood the system better, they would use it more effectively. However, for most Medicare patients, that assumption is wrong. The barrier to care isn’t knowledge, it’s execution. The post Medicare Patients Don’t Need More Information —They Need Someone to Act appeared first on MedCity News.
Atrium spun out of Avidity Biosciences, which Novartis acquired in a $12 billion deal. The Atrium pipeline is led by two RNA therapies with a path to the clinic for rare inherited cardiological disorders that have no FDA-approved drugs. The post Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions appeared first…
The label expansion for Boehringer Ingelheim’s Hernexeos was made under an FDA pilot program that accelerates regulatory review of products with national interest. The daily pill is now approved as a first-line treatment for HER2-positive non-small lung cancer, an indication with few treatment options. The post FDA Voucher Leads to Speedy Approval of Boehringer Drug…